List of insiders holdings for Trillium Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Reynolds Thomas C Director |
2021-01-04 20:20:27 | 643,532 0 |
643,532 | Form 3 |
| 2 | KIRKMAN ROBERT L Director |
2021-01-04 20:13:39 | 519,290 0 |
519,290 | Form 3 |
| 3 | Skvarka Jan President and CEO |
2021-11-19 13:20:57 | 0 0 |
0 | Form 4 |
| 4 | TAYTON-MARTIN HELEN KATRINA Director |
2021-11-19 13:22:11 | 0 0 |
0 | Form 4 |
| 5 | Uger Robert Chief Scientific Officer |
2021-11-19 13:23:23 | 0 0 |
0 | Form 4 |
| 6 | Petrova Penka Chief Development Officer |
2021-11-19 13:24:24 | 0 0 |
0 | Form 4 |
| 7 | Bruns Ingmar Chief Medical Officer |
2021-11-19 13:25:14 | 0 0 |
0 | Form 4 |
| 8 | MACKEY CATHERINE J Director |
2021-11-19 13:26:15 | 0 0 |
0 | Form 4 |
| 9 | Looker Benjamin General Counsel |
2021-11-19 13:27:14 | 0 0 |
0 | Form 4 |
| 10 | Kamarck Michael E. Director |
2021-11-19 13:28:05 | 0 0 |
0 | Form 4 |
| 11 | Parsons James T. Chief Financial Officer |
2021-11-19 13:29:14 | 0 0 |
0 | Form 4 |
| 12 | BESHAR LUKE M Director |
2021-11-19 13:30:09 | 0 0 |
0 | Form 4 |
| 13 | Harrison Rosemary See Remarks |
2021-11-19 13:30:58 | 0 0 |
0 | Form 4 |
| 14 | Myers Scott Dunseth Director |
2021-11-19 13:33:02 | 0 0 |
0 | Form 4 |
| 15 | Pucci Paolo Director |
2021-11-19 13:33:49 | 0 0 |
0 | Form 4 |
| 16 | Walker Paul Edward Director |
2021-11-19 15:34:15 | 0 0 |
0 | Form 4 |